{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:16:19Z","timestamp":1791404179115,"version":"4.3.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T00:00:00Z","timestamp":1527724800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13075-018-1601-4","type":"journal-article","created":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T09:03:54Z","timestamp":1527671034000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Comparison of US patient, rheumatologist, and dermatologist perceptions of psoriatic disease symptoms: results from the DISCONNECT study"],"prefix":"10.1186","volume":"20","author":[{"given":"M. Elaine","family":"Husni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Hauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Posner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie","family":"Sutphin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arijit","family":"Ganguli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,31]]},"reference":[{"key":"1601_CR1","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/j.1365-4632.2012.05798.x","volume":"53","author":"M Lebwohl","year":"2014","unstructured":"Lebwohl M, Swensen AR, Nyirady J, Kim E, Gwaltney CJ, Strober BE. The psoriasis symptom diary: development and content validity of a novel patient-reported outcome instrument. Int J Dermatol. 2014;53:714\u201322.","journal-title":"Int J Dermatol"},{"key":"1601_CR2","unstructured":"National Psoriasis Foundation. About psoriatic arthritis. \n                    https:\/\/www.psoriasis.org\/about-psoriatic-arthritis\n                    \n                  . Accessed 5 Jun 2015."},{"key":"1601_CR3","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMra1505557","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017;376:957\u201370.","journal-title":"N Engl J Med"},{"key":"1601_CR4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s40259-013-0025-6","volume":"27","author":"E Gan","year":"2013","unstructured":"Gan E, Chong W, Tey H. Therapeutic strategies in psoriasis patients with psoriatic arthritis: focus on new agents. BioDrugs. 2013;27:359\u201373.","journal-title":"BioDrugs"},{"key":"1601_CR5","first-page":"S225","volume":"22","author":"A Menter","year":"2016","unstructured":"Menter A. Psoriasis and psoriatic arthritis treatment. Am J Manag Care. 2016;22:S225\u201337.","journal-title":"Am J Manag Care"},{"key":"1601_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jaad.2010.11.055","volume":"65","author":"A Menter","year":"2011","unstructured":"Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 6: Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. J Am Acad Dermatol. 2011;65:137.","journal-title":"J Am Acad Dermatol"},{"key":"1601_CR7","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.jaad.2008.02.040","volume":"58","author":"A Gottlieb","year":"2008","unstructured":"Gottlieb A, Korman N, Gordon K, Feldman S, Lebwohl M, Koo JY, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol. 2008;58:851\u201364.","journal-title":"J Am Acad Dermatol"},{"key":"1601_CR8","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/acr.22401","volume":"67","author":"L Eder","year":"2015","unstructured":"Eder L, Thavaneswaran A, Chandran V, Cook R, Gladman DD. Factors explaining the discrepancy between physician and patient global assessment of joint and skin disease activity in psoriatic arthritis patients. Arthritis Care Res (Hoboken). 2015;67:264\u201372.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1601_CR9","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1136\/annrheumdis-2016-210283","volume":"76","author":"B Michelsen","year":"2017","unstructured":"Michelsen B, Kristianslund EK, Hammer HB, Fagerli KM, Lie E, Wier\u00f8d A, et al. Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of remission in patients with rheumatoid arthritis and psoriatic arthritis: data from the prospective multicentre NOR-DMARD study. Ann Rheum Dis. 2017;76:708\u201311.","journal-title":"Ann Rheum Dis"},{"key":"1601_CR10","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1002\/acr.23172","volume":"69","author":"C Desthieux","year":"2017","unstructured":"Desthieux C, Granger B, Balanescu AR, Balint P, Braun J, Canete JD, et al. Determinants of patient-physician discordance in global assessment in psoriatic arthritis: a multicenter European study. Arthritis Care Res (Hoboken). 2017;69:1606\u201311.","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"1601_CR11","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.3899\/jrheum.150007","volume":"42","author":"C Lindstr\u00f6m Egholm","year":"2015","unstructured":"Lindstr\u00f6m Egholm C, Krogh NS, Pincus T, Dreyer L, Ellingsen T, Glintborg B, et al. Discordance of global assessments by patient and physician is higher in female than in male patients regardless of the physician's sex: data on patients with rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis from the DANBIO Registry. J Rheumatol. 2015;42:1781\u20135.","journal-title":"J Rheumatol"},{"key":"1601_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s40744-016-0029-z","volume":"3","author":"A Kavanaugh","year":"2016","unstructured":"Kavanaugh A, Helliwell P, Ritchlin CT. Psoriatic arthritis and burden of disease: patients perspectives from the population-based multinational assessment of psoriasis and psoriatic arthritis (MAPP) survey. Rheumatol Ther. 2016;3:91\u2013102.","journal-title":"Rheumatol Ther"},{"key":"1601_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jhealeco.2006.04.002","volume":"26","author":"TN Flynn","year":"2007","unstructured":"Flynn TN, Louviere JJ, Peters TJ, Coast J. Best-worst scaling: what it can do for health care research and how to do it. J Health Econ. 2007;26:171\u201389.","journal-title":"J Health Econ"},{"key":"1601_CR14","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9781107337855","volume-title":"Best-worst scaling: theory, methods, and applications","author":"JJ Louviere","year":"2015","unstructured":"Louviere JJ, Flynn TN, Marley AAJ. Best-worst scaling: theory, methods, and applications. Cambridge: Cambridge University Press; 2015."},{"key":"1601_CR15","first-page":"1101","volume":"10","author":"JM Nolla","year":"2016","unstructured":"Nolla JM, Rodr\u00edguez M, Martin-Mola E, Raya E, Ibero I, Nocea G, et al. Patients\u2019 and rheumatologists\u2019 preferences for the attributes of biological agents used in the treatment of rheumatic diseases in Spain. Patient Prefer Adherence. 2016;10:1101\u201313. eCollection 2016","journal-title":"Patient Prefer Adherence."},{"key":"1601_CR16","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2340\/00015555-1304","volume":"92","author":"N Umar","year":"2012","unstructured":"Umar N, Yamamoto S, Loerbroks A, Terris D. Elicitation and use of patients\u2019 preferences in the treatment of psoriasis: a systematic review. Acta Derm Venereol. 2012;92:341\u20136.","journal-title":"Acta Derm Venereol"},{"key":"1601_CR17","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3109\/09546634.2015.1034071","volume":"26","author":"TL Kauf","year":"2015","unstructured":"Kauf TL, Yang JC, Kimball AB, Sundaram M, Bao Y, Okun M, et al. Psoriasis patients\u2019 willingness to accept side-effect risks for improved treatment efficacy. Dermatolog Treat. 2015;26:507\u201313.","journal-title":"Dermatolog Treat"},{"key":"1601_CR18","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3109\/09546634.2011.588193","volume":"22","author":"AB Hauber","year":"2011","unstructured":"Hauber AB, Gonzalez JM, Schenkel B, Lofland J, Martin S. The value to patients of reducing lesion severity in plaque psoriasis. J Dermatolog Treat. 2011;22:266\u201375.","journal-title":"J Dermatolog Treat"},{"key":"1601_CR19","first-page":"997","volume":"159","author":"MK Basra","year":"2008","unstructured":"Basra MK, Fenech R, Gatt RM, Salek MS, Finlay AY. The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol. 2008;159:997\u20131035.","journal-title":"Br J Dermatol"},{"key":"1601_CR20","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/art.22605","volume":"57","author":"TA Stamm","year":"2007","unstructured":"Stamm TA, Nell V, Mathis M, Coenen M, Aletaha D, Cieza A, et al. Concepts important to patients with psoriatic arthritis are not adequately covered by standard measures of functioning. Arthritis Rheum. 2007;57:487\u201394.","journal-title":"Arthritis Rheum"},{"key":"1601_CR21","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1136\/annrheumdis-2014-205207","volume":"73","author":"L Gossec","year":"2014","unstructured":"Gossec L, de Wit M, Kiltz U, Braun J, Kalyoncu U, Scrivo R, et al. A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative. Ann Rheum Dis. 2014;73:1012\u20139.","journal-title":"Ann Rheum Dis"},{"key":"1601_CR22","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jbspin.2015.07.017","volume":"83","author":"T Gudu","year":"2016","unstructured":"Gudu T, Etcheto A, de Wit M, Heiberg T, Maccarone M, Balanescu A, et al. Fatigue in psoriatic arthritis\u2014a cross-sectional study of 246 patients from 13 countries. Joint Bone Spine. 2016;83:439\u201343.","journal-title":"Joint Bone Spine"},{"key":"1601_CR23","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1185\/03007995.2014.921611","volume":"30","author":"Z Yuan","year":"2014","unstructured":"Yuan Z, Levitan B, Burton P, Poulos C, Hauber AB, Berlin JA. Relative importance of benefits and risks associated with antithrombotic therapies for acute coronary syndrome: patient and physician perspectives. Curr Med Res Opin. 2014;30:1733\u201341.","journal-title":"Curr Med Res Opin"},{"key":"1601_CR24","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511753930","volume-title":"Discrete choice methods with simulation","author":"K Train","year":"2003","unstructured":"Train K. Discrete choice methods with simulation. 1st ed. Cambridge: Cambridge University Press; 2003.","edition":"1"},{"key":"1601_CR25","doi-asserted-by":"crossref","unstructured":"Train K, Sonnier G. Mixed logit with bounded distributions of correlated partworths. In: Scarpa R, Alberini A, editors. Applications of simulation methods in environmental and resource economics. Dordrecht: Springer Publisher; 2005. p. 117\u201334.","DOI":"10.1007\/1-4020-3684-1_7"},{"key":"1601_CR26","unstructured":"Sawtooth Software, Inc. (2013). The MaxDiff\/Web system technical paper. Provo: Sawtooth Software Technical Paper Series."},{"key":"1601_CR27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/annrheumdis-2013-203419","volume":"73","author":"JS Smolen","year":"2014","unstructured":"Smolen JS, Braun J, Dougados M, Emery P, Fitzgerald O, Helliwell P, et al. Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis. 2014;73:6\u201316.","journal-title":"Ann Rheum Dis"},{"key":"1601_CR28","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.2147\/PPA.S117006","volume":"10","author":"I Belinch\u00f3n","year":"2016","unstructured":"Belinch\u00f3n I, Rivera R, Blanch C, Comellas M, Liz\u00e1n L. Adherence, satisfaction and preferences for treatment in patients with psoriasis in the European union: a systematic review of the literature. Patient Prefer Adherence. 2016;10:2357\u201367. eCollection 2016","journal-title":"Patient Prefer Adherence."},{"key":"1601_CR29","doi-asserted-by":"publisher","first-page":"777","DOI":"10.2147\/PPA.S85773","volume":"9","author":"M Zhang","year":"2015","unstructured":"Zhang M, Brenneman SK, Carter CT, Essoi BL, Farahi K, Johnson MP, et al. Patient-reported treatment satisfaction and choice of dosing frequency with biologic treatment for moderate to severe plaque psoriasis. Patient Prefer Adherence. 2015;9:777\u201384.","journal-title":"Patient Prefer Adherence"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1601-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-018-1601-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1601-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T19:14:23Z","timestamp":1559243663000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-018-1601-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,31]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1601"],"URL":"https:\/\/doi.org\/10.1186\/s13075-018-1601-4","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,31]]},"assertion":[{"value":"21 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by RTI International\u2019s Office of Research Protection (ID 13967). All respondents provided informed consent at the time of completing the survey.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"MEH is a consultant to AbbVie and Janssen, and has served on advisory boards for AbbVie, Celgene, Genentech, Bristol-Myers Squibb, Lilly, Pfizer, Novartis, and Janssen. AF is a speaker as well as a consultant to AbbVie, and has served as a researcher for Mallinkrodt, Roche, and AbbVie. BH and JS are full-time employees of RTI Health Solutions, which has received consulting fees from AbbVie to partner on this research. JP was a full-time employee of RTI Health Solutions when this research was conducted. RS and AG are full-time AbbVie employees and own AbbVie stock.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"102"}}